Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Hosaka

Showing results (251-260 of 306) with videos related to

Pageof 31
Sort By:
Scandinavian Journal of Gastroenterology|June 13, 2009
Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levelsMariko Kobayashi, Fumitaka Suzuki, Norio Akuta, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 22, 2009
Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeksFumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, et al.
The American Journal of Gastroenterology|October 20, 2011
Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinomaYusuke Kawamura, Yasuji Arase, Kenji Ikeda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 3, 2018
No-touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resectionYusuke Kawamura, Kenji Ikeda, Junichi Shindoh, et al.
Intervirology|February 18, 2011
Amino acid substitution in HCV core region and genetic variation near the IL28B gene affect viral dynamics during telaprevir, peginterferon and ribavirin treatmentNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 5, 2012
Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1bFumitaka Suzuki, Hitomi Sezaki, Norio Akuta, et al.
Internal Medicine (Tokyo, Japan)|February 26, 2019
The Lack of Hepatocyte Steatosis in Adult-onset Type II Citrullinemia Patients as Assessed by 7-year Interval Paired BiopsiesHiroyuki Suzuki, Yusuke Kawamura, Keiichi Kinowaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 3, 2011
Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapyYasuji Arase, Fumitaka Suzuki, Yusuke Kawamura, et al.
BMC Gastroenterology|November 5, 2020
Non-invasive predictors of prognosis of Asian patients with histopathologically-confirmed lean nonalcoholic fatty liver diseaseSoichi Iritani, Norio Akuta, Yusuke Kawamura, et al.
Clinical Journal of Gastroenterology|August 1, 2022
A case of drug-induced acute liver failure caused by corticosteroidsAkira Kajiwara, Yusuke Kawamura, Keiichi Kinowaki, et al.
Pageof 31

Showing results (251-260 of 306) with videos related to

Sort By:
Pageof 31
Scandinavian Journal of Gastroenterology|June 13, 2009
Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levelsMariko Kobayashi, Fumitaka Suzuki, Norio Akuta, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 22, 2009
Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeksFumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, et al.
The American Journal of Gastroenterology|October 20, 2011
Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinomaYusuke Kawamura, Yasuji Arase, Kenji Ikeda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 3, 2018
No-touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resectionYusuke Kawamura, Kenji Ikeda, Junichi Shindoh, et al.
Intervirology|February 18, 2011
Amino acid substitution in HCV core region and genetic variation near the IL28B gene affect viral dynamics during telaprevir, peginterferon and ribavirin treatmentNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 5, 2012
Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1bFumitaka Suzuki, Hitomi Sezaki, Norio Akuta, et al.
Internal Medicine (Tokyo, Japan)|February 26, 2019
The Lack of Hepatocyte Steatosis in Adult-onset Type II Citrullinemia Patients as Assessed by 7-year Interval Paired BiopsiesHiroyuki Suzuki, Yusuke Kawamura, Keiichi Kinowaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 3, 2011
Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapyYasuji Arase, Fumitaka Suzuki, Yusuke Kawamura, et al.
BMC Gastroenterology|November 5, 2020
Non-invasive predictors of prognosis of Asian patients with histopathologically-confirmed lean nonalcoholic fatty liver diseaseSoichi Iritani, Norio Akuta, Yusuke Kawamura, et al.
Clinical Journal of Gastroenterology|August 1, 2022
A case of drug-induced acute liver failure caused by corticosteroidsAkira Kajiwara, Yusuke Kawamura, Keiichi Kinowaki, et al.
Pageof 31